Literature DB >> 7092811

Isolation, characterization and N-terminal sequences of the CNBr-cleavage peptides from human complement Factor B. Localization of a free thiol group and a sequence defining the site cleaved by factor D.

D L Christie, J Gagnon.   

Abstract

Nine CNBr-cleavage peptides from Factor B (a component of the alternative pathway of complement) were isolated. Each was characterized by amino acid analysis and automated Edman degradation. One peptide contained a methionyl bond resistant to cleavage by CNBr. The number of CNBr-cleavage peptides is in agreement with the results of amino acid analysis of Factor B and the fragments Ba and Bb. A total of 358 unique residues were identified from the N-terminal sequences of the CNBr-cleavage peptides. These represent approx. 50% and 60% of the total residues of Factor B and fragment Bb respectively. Alignment of two CNBr-cleavage peptides (CB-VIc and CB-IV) provided a continuous segment of 140 residues. This sequence contained the site cleaved by Factor D to generate the Ba and Bb fragments during the activation of complement. Peptide CB-IV contained a free thiol group at a position corresponding to residue 33 of fragment Bb. Amino sugar analyses of Factor B and of fragments Bb and Ba indicated that all the carbohydrate structures of factor B are N-linked to asparagine through N-acetylglucosamine. The two carbohydrate-attachment sites of the Bb fragment were identified.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7092811      PMCID: PMC1163682          DOI: 10.1042/bj2010555

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  The serine protease nature of the C3 and C5 convertases of the classical and alternative complement pathways.

Authors:  R G Medicus; O Götze; H J Müller-Eberhard
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

2.  The quantitation of glucosamine and galactosamine in glycoproteins after hydrolysis in p-toluenesulphonic acid.

Authors:  A K Allen; A Neuberger
Journal:  FEBS Lett       Date:  1975-12-01       Impact factor: 4.124

Review 3.  A molecular approach to the complement system.

Authors:  J E Fothergill; W H Anderson
Journal:  Curr Top Cell Regul       Date:  1978

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 5.  Comparative aspects of glycoprotein structure.

Authors:  R Kornfeld; S Kornfeld
Journal:  Annu Rev Biochem       Date:  1976       Impact factor: 23.643

6.  Amino-terminal sequence of human factor B of the alternative complement pathway and its cleavage fragments, Ba and Bb.

Authors:  M A Niemann; J E Volanakis; J E Mole
Journal:  Biochemistry       Date:  1980-04-15       Impact factor: 3.162

7.  The alternative pathway C3/C5 convertase: chemical basis of factor B activation.

Authors:  P H Lesavre; T E Hugli; A F Esser; H J Müller-Eberhard
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

8.  Direct microsequence analysis of polypeptides using an improved sequenator, a nonprotein carrier (polybrene), and high pressure liquid chromatography.

Authors:  M W Hunkapiller; L E Hood
Journal:  Biochemistry       Date:  1978-05-30       Impact factor: 3.162

9.  Limited proteolysis of complement components C2 and factor B. Structural analogy and limited sequence homology.

Authors:  M A Kerr
Journal:  Biochem J       Date:  1979-12-01       Impact factor: 3.857

10.  Structural evidence that complement factor B constitutes a novel class of serine protease.

Authors:  J E Mole; M A Niemann
Journal:  J Biol Chem       Date:  1980-09-25       Impact factor: 5.157

View more
  15 in total

1.  The effects of autolysis on the structure of chicken calpain II.

Authors:  C Crawford; A C Willis; J Gagnon
Journal:  Biochem J       Date:  1987-12-01       Impact factor: 3.857

2.  Sequence polymorphism of human complement factor H.

Authors:  A J Day; A C Willis; J Ripoche; R B Sim
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

3.  The complete amino acid sequence of human complement factor H.

Authors:  J Ripoche; A J Day; T J Harris; R B Sim
Journal:  Biochem J       Date:  1988-01-15       Impact factor: 3.857

4.  CNBr cleavage of the light chain of human complement factor I and alignment of the fragments.

Authors:  J M Yuan; L M Hsiung; J Gagnon
Journal:  Biochem J       Date:  1986-01-15       Impact factor: 3.857

5.  Amino acid sequence of the Bb fragment from human complement Factor B. Alignment of the cyanogen bromide-cleavage peptides.

Authors:  J Gagnon; D L Christie
Journal:  Biochem J       Date:  1983-01-01       Impact factor: 3.857

6.  Purification of human C3b inactivator by monoclonal-antibody affinity chromatography.

Authors:  L Hsiung; A N Barclay; M R Brandon; E Sim; R R Porter
Journal:  Biochem J       Date:  1982-04-01       Impact factor: 3.857

7.  Complete amino acid sequence of the A chain of human complement-classical-pathway enzyme C1r.

Authors:  G J Arlaud; A C Willis; J Gagnon
Journal:  Biochem J       Date:  1987-02-01       Impact factor: 3.857

8.  Chemical modification of the haem propionate of cytochrome c. A re-evaluation of the reaction of cytochrome c with a water-soluble carbodi-imide.

Authors:  A J Mathews; T Brittain
Journal:  Biochem J       Date:  1986-11-15       Impact factor: 3.857

9.  Primary structure of the A chain of human complement-classical-pathway enzyme C1r. N-terminal sequences and alignment of autolytic fragments and CNBr-cleavage peptides.

Authors:  J Gagnon; G J Arlaud
Journal:  Biochem J       Date:  1985-01-01       Impact factor: 3.857

10.  The reaction of iodine and thiol-blocking reagents with human complement components C2 and factor B. Purification and N-terminal amino acid sequence of a peptide from C2a containing a free thiol group.

Authors:  C Parkes; J Gagnon; M A Kerr
Journal:  Biochem J       Date:  1983-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.